Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel G Anderson

Showing results (1-10 of 363) with videos related to

Pageof 37
Sort By:
Accounts of Chemical Research|January 4, 2022
Opportunities and Challenges in mRNA TherapeuticsYizhou Dong, Daniel G Anderson
Nature Biotechnology|July 10, 2009
Minicells overcome tumor drug-resistanceEmmanouil D Karagiannis, Daniel G Anderson
Med (New York, N.Y.)|May 19, 2022
Nanoscale delivery platforms for RNA therapeutics: Challenges and the current state of the artLuke H Rhym, Daniel G Anderson
Journal of Drug Targeting|October 11, 2015
Smart approaches to glucose-responsive drug deliveryMatthew J Webber, Daniel G Anderson
ACS Nano|July 30, 2016
Spatial Control of Gene Expression by Nanocarriers Using Heparin Masking and Ultrasound-Targeted Microbubble DestructionBeata Chertok, Robert Langer, Daniel G Anderson
Nature Biotechnology|June 15, 2004
Nanoliter-scale synthesis of arrayed biomaterials and application to human embryonic stem cellsDaniel G Anderson, Shulamit Levenberg, Robert Langer
Nature Reviews. Clinical Oncology|January 22, 2019
CRISPR-Cas: a tool for cancer research and therapeuticsHao Yin, Wen Xue, Daniel G Anderson
Advanced Drug Delivery Reviews|June 30, 2016
Physical and mechanical properties of PLA, and their functions in widespread applications - A comprehensive reviewShady Farah, Daniel G Anderson, Robert Langer
Trends in Molecular Medicine|June 26, 2021
mRNA therapeutics: beyond vaccine applicationsBalkrishen Bhat, Shrirang Karve, Daniel G Anderson
Nano Letters|March 29, 2023
<i>In Vivo</i> RNA Delivery to Hematopoietic Stem and Progenitor Cells <i>via</i> Targeted Lipid NanoparticlesDennis Shi, Sho Toyonaga, Daniel G Anderson
Pageof 37

Showing results (1-10 of 363) with videos related to

Sort By:
Pageof 37
Accounts of Chemical Research|January 4, 2022
Opportunities and Challenges in mRNA TherapeuticsYizhou Dong, Daniel G Anderson
Nature Biotechnology|July 10, 2009
Minicells overcome tumor drug-resistanceEmmanouil D Karagiannis, Daniel G Anderson
Med (New York, N.Y.)|May 19, 2022
Nanoscale delivery platforms for RNA therapeutics: Challenges and the current state of the artLuke H Rhym, Daniel G Anderson
Journal of Drug Targeting|October 11, 2015
Smart approaches to glucose-responsive drug deliveryMatthew J Webber, Daniel G Anderson
ACS Nano|July 30, 2016
Spatial Control of Gene Expression by Nanocarriers Using Heparin Masking and Ultrasound-Targeted Microbubble DestructionBeata Chertok, Robert Langer, Daniel G Anderson
Nature Biotechnology|June 15, 2004
Nanoliter-scale synthesis of arrayed biomaterials and application to human embryonic stem cellsDaniel G Anderson, Shulamit Levenberg, Robert Langer
Nature Reviews. Clinical Oncology|January 22, 2019
CRISPR-Cas: a tool for cancer research and therapeuticsHao Yin, Wen Xue, Daniel G Anderson
Advanced Drug Delivery Reviews|June 30, 2016
Physical and mechanical properties of PLA, and their functions in widespread applications - A comprehensive reviewShady Farah, Daniel G Anderson, Robert Langer
Trends in Molecular Medicine|June 26, 2021
mRNA therapeutics: beyond vaccine applicationsBalkrishen Bhat, Shrirang Karve, Daniel G Anderson
Nano Letters|March 29, 2023
<i>In Vivo</i> RNA Delivery to Hematopoietic Stem and Progenitor Cells <i>via</i> Targeted Lipid NanoparticlesDennis Shi, Sho Toyonaga, Daniel G Anderson
Pageof 37